New this year at TCT is the Presentation Theater, located in the Exhibit Hall. This theater will include the Case Consultation session, the Electronic Health Records session, the Hypothetical Case Presentation session, and sessions from industry concerning the latest developments in cardiovascular devices. Presentation Theater sessions are non-CME.
Tuesday, September 22
Room 121, 12:00 pm-1:00 pm
Within-the-Tunnel PFO Closure: Refining Your Approach and Treating the Tunnel Using the Coherex FlatStent™ EF PFO Closure System
Sponsored by Coherex, Inc.
Lunch will be provided.The Coherex FlatStent™ EF PFO Closure System is the first within-the-tunnel device to receive a CE mark. This session will present an overview of the device, how it is used, up-to-date clinical results, and tips and tricks on sizing and device selection. The FlatStent™ EF is designed with the intent to minimize exposed surface area, minimize septal distortion, reduce the risk of tissue erosion, and reduce the risk of air embolism by incorporating rapid exchange delivery.
To register, please contact Kathleen Carter at This e-mail address is being protected from spambots. You need JavaScript enabled to view it or 801-433-9900.
Wednesday, September 23
Exhibit Hall, 11:00 am-4:15 pm
11:00 am-12:00 pm
Case Consultation Session
Physicians were invited to submit their challenging cases to receive consultation from TCT Faculty on how to treat their patients.
Moderator: Giora Weisz
Discussants: Mark W. Connolly, Eulogio Garcia, Igor F. Palacios12:30 pm-1:30 pm
Key Opinion Leader Discussion of the Important Role Low-Osmolar, Ionic Contrast Media Can Play in Improving Patient Outcomes
Sponsored by Guerbet LLC
Lunch will be provided.This Key Opinion Leader Lunch Program will be presenting data on the role of low-osmolar, ionic contrast media including insights from an endovascular perspective as well as a discussion of interventional cardiac procedures.
Moderators: Samuel M. Butman, Bhagat K. ReddyTo register, please contact Melissa Buchanan at This e-mail address is being protected from spambots. You need JavaScript enabled to view it or 877-729-6679.
2:00 pm-3:00 pm
The Future of Interventional Medicine: What Will Interventional Cardiologists Be Doing in Five Years?
Sponsored by Medtronic, Inc.
Chair: Mark A. Turco
Speakers: Jeffrey J. Popma, Krishna J. Rocha-Singh, James P. ZidarExpert panel and audience discussion on how continued innovation will change the face of interventional medicine, training needs, and practice management. The goal of this session is to provide attendees with important insights into the adjustments they should be considering for their future practices.
To register, please visit www.seeuthere.com/FutureInterventionalMedicine.
3:15 pm-4:15 pm
A Satirical Case Presentation from the BBC
Moderators: David Hildick-Smith, Martyn R. Thomas
Thursday, September 24
Exhibit Hall, 9:30 am-4:15 pm
9:30 am-12:00 pm
Electronic Health Records: What You Need to Know
Leading experts will discuss the latest developments in Electronic Health Records (EHR) and its relevance to health care reform. The session will include solutions for integrated health systems, with the pros and cons.
9:30 am The NewYork-Presbyterian Experience: EHR Solutions for Integrated Health Systems
Aurelia G. Boyer9:55 am EHR Solutions: The Private Practice Setting
TBA10:20 am ARRA, Certification, Meaningful Use, Interoperability: How Will This Affect Me?
James E. Tcheng, Professor of Medicine and Medical Knowledge Architect, Duke University Health System10:45 am Personal Health Records: Putting the "Me" in "Medicine"
David Feinberg, Grad Conn11:10 am Roundtable Discussion 11:35 am "CVIS": Integrated Cardiovascular Information Systems: The Way of the Future?
Jeremy Bikman12:30 pm-1:30 pm
A Modern Day Approach to Vascular Advancement
Sponsored by Abbott Vascular
Lunch will be provided.The SPIRIT Trials have consistently shown strong results of XIENCE V compared to TAXUS. Join Chuck Simonton, MD, Abbott Vascular Chief Medical Officer, and two physician speakers who will debate the results of the latest XIENCE V SPIRIT data and their impact on the selection of DES for patients.
To register, please contact Rachelle Bell at This e-mail address is being protected from spambots. You need JavaScript enabled to view it .
2:00 pm-3:00 pm
A Newly Developed Antiplatelet Therapy for Patients with Acute Coronary Syndrome Managed with PCI
Sponsored by Daiichi Sankyo, Inc. and Lilly USA, LLC
This presentation focuses on a new antiplatelet therapy for patients with acute coronary syndrome managed with PCI.
3:15 pm-4:15 pm
The AZNET Hypothetical Case Presentation
Moderator: Ian T. Meredith





View the Japanese version of this website.